IQVIA
IQV
#614
Rank
$42.76 B
Marketcap
$259.82
Share price
1.47%
Change (1 day)
40.15%
Change (1 year)

P/E ratio for IQVIA (IQV)

P/E ratio as of August 2026 (TTM): 31.7

According to IQVIA's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 31.7033. At the end of 2025 the company had a P/E ratio of 28.4.

P/E ratio history for IQVIA from 2013 to 2026

PE ratio at the end of each year

Year P/E ratio Change
202528.49.64%
202425.9-16.98%
202331.2-11.46%
202235.3-36.88%
202155.9
201915872.36%
201891.5479.29%
201715.8-64.5%
201644.5104.04%
201521.82.93%
201421.2

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
Nymox Pharmaceutical
NYMX
-3.33-110.51% Bahamas
NRC Health
NRC
56.5 78.30%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.